1. SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients. Issue 1 (14th March 2022) Authors: Vetter, Marcus; Rothgiesser, Karin M; Li, Qiyu; Hawle, Hanne; Schönfeld, Wolfgang; Ribi, Karin; Riniker, Salome; von Moos, Roger; Trojan, Andreas; Kralidis, Elena; Fehr, Mathias; Müller, Andreas; Thürlimann, Beat Journal: Endocrine oncology Issue: Volume 2:Issue 1(2022) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗